The practical answer
FDA approval belongs to a specific product and application, not to a molecule name on someone else's label. Search Drugs@FDA and, for licensed biological products, the Purple Book; then match sponsor, product name, dosage form and application number. FDA states that registration, listing and NDC assignment do not denote approval. [1] [2] [5]
Evidence, method & source dates ↓Why a peptide name is not an approval status
A seller may write that a peptide is "FDA-approved" because an approved medicine contains the same named ingredient, or because the seller has a registration or an NDC number. Those are different facts. FDA explains that new drugs and biological products for people generally must be approved before marketing, while compounded drugs are not FDA approved and mere registration of an establishment or listing of a drug does not denote approval. [1]
This guide shows how to check status in FDA's public databases and how to write down what you found. It is a documentation method for procurement and research reading. It is not medical advice and does not address whether any product is appropriate for a person.
Search the database that matches the product type
Drugs@FDA covers drugs, including biological products, approved for human use in the United States, and typically provides labeling, regulatory information and FDA reviews for prescription brand-name drugs. It does not include FDA-approved products regulated by the Center for Biologics Evaluation and Research. [2]
The Orange Book identifies drug products approved on the basis of safety and effectiveness, with patent, exclusivity and therapeutic-equivalence information. [3] The Purple Book is FDA's database of licensed biological products, including biosimilar and interchangeable products. [4] Size matters for classification: FDA's final rule defines a "protein" as an alpha amino acid polymer with a specific, defined sequence greater than 40 amino acids in size. [6] When you are unsure which pathway applies, search both Drugs@FDA and the Purple Book and record both results.
| Database | Use it to answer | Limit to record |
|---|---|---|
| Drugs@FDA | Which approved products contain this active ingredient, under which application? [2] | Excludes CBER-regulated products [2] |
| Orange Book | Is this approved drug product listed, and with what equivalence rating? [3] | Describes approved drug products only |
| Purple Book | Is this biological product licensed? [4] | Licensed biologics only |
| NDC Directory | Has a labeler listed this product? [5] | Includes unapproved drugs; NDC is not approval [5] |
The NDC and registration trap
FDA's NDC Directory states that it contains approved and unapproved drugs as well as repackaged and relabeled drugs, that assignment of an NDC number does not in any way denote FDA approval, and that the content of each entry is the labeler's responsibility. [5] A product page that quotes an NDC, a facility registration or "FDA-registered" wording has therefore not shown approval.
Record the exact wording the seller uses. "Manufactured in an FDA-registered facility" is a claim about a facility; "FDA-approved" is a claim about a product. If the second appears, the seller should be able to name the application. If they cannot, mark the claim unsupported rather than guessing.
A fictional verification record
Suppose an invented listing says "peptide X, FDA-approved ingredient, research use only." Searching Drugs@FDA for peptide X returns one approved injectable product from sponsor S under application N. The listing's vial comes from a different company, uses a different presentation and names no application.
The defensible note is: "An approved product containing peptide X exists (sponsor S, application N). The offered vial is not that product, and the seller identified no application covering it." Do not write that the offered material is approved, and do not write that it is unsafe; neither follows from the database search.
Fields to capture before you file the result
Write the search term, database, date, and every matching application with sponsor, product name, dosage form and status. Include a screenshot or saved page if your organization allows it. If nothing matches, record "no match on this date for these search terms" and the alternative names you tried, including salt forms and code names.
Status can change after your search, and databases have scope limits. A dated, scoped record is more useful to a reviewer than a one-word answer, and it can be rechecked quickly when the question returns.
Questions before you decide
If an approved drug contains the same peptide, is a research vial of that peptide approved?
No. Approval attaches to a specific product under an application. A different product with the same named ingredient needs its own basis, and FDA warns that compounded and research-labeled versions of approved ingredients are not approved products.
Does an NDC number prove approval?
No. FDA states that NDC assignment does not denote approval and that the NDC Directory includes unapproved drugs.
Check the underlying evidence
Sources & review dates
- FDA: Is It Really 'FDA Approved'? ↗Accessed 13 Oct 2026
- FDA: Drugs@FDA database ↗Accessed 13 Oct 2026
- FDA: Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) ↗Accessed 13 Oct 2026
- FDA: Purple Book, about the database ↗Accessed 13 Oct 2026
- FDA: National Drug Code Directory ↗Accessed 13 Oct 2026
- FDA: Definition of the Term "Biological Product" final regulatory impact analysis ↗Accessed 13 Oct 2026
Sources are documentary evidence. They do not establish firsthand testing of a listed supplier.